Publications Office of the EU
Medicines for rare diseases and severe sepsis through the National Program - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Medicines for rare diseases and severe sepsis through the National Program

  • Published
    06/10/2025
  • Deadline
    03/11/2025
  • Opening of tenders
    03/11/2025
  • Today
    09/05/2026
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
SPITALUL CLINIC DE NEFROLOGIE "DR. CAROL DAVILA"
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: RO321 Bucureşti
Business sector (Main CPV)
33652000 Antineoplastic and immunomodulating agents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
3
Tender reference number
3430
Description

Medicines for rare diseases and severe sepsis through the National Program as specified in the specification

Submission Method
Electronic via:
https://www.e-licitatie.ro
Tenders may be submitted
Electronic submission: required
https://www.e-licitatie.ro
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
03/11/2025 14:00
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.